Dr Euphemia Leung

Research | Current

Research interests

Research group

Selected publications and creative works (Research Outputs)

As of 29 October 2020 there will be no automatic updating of 'selected publications and creative works' from Research Outputs. Please continue to keep your Research Outputs profile up to date.
  • Hanif, M., Arshad, J., Astin, J. W., Rana, Z., Zafar, A., Movassaghi, S., ... Reynisson, J. (2020). A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor. Angewandte Chemie, 132 (34), 14717-14722. 10.1002/ange.202005758
    Other University of Auckland co-authors: Tilo Söhnel, Muhammad Hanif, Jonathan Astin, Stephen Jamieson, Christian Hartinger
  • Chang, Y.-C., Kondapuram, S. K., Yang, T.-H., Syed, S. B., Cheng, S. M., Lin, T.-Y., ... Leung, E. (2020). The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells. Toxicology and applied pharmacology, 40110.1016/j.taap.2020.115080
  • Lin, T.-Y., Chan, H.-H., Chen, S.-H., Sarvagalla, S., Chen, P.-S., Coumar, M. S., ... Leung, E. (2020). BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy, 16 (7), 1296-1313. 10.1080/15548627.2019.1671643
  • Singleton, D. C., Dechaume, A.-L., Murray, P. M., Katt, W. P., Baguley, B. C., & Leung, E. Y. (2020). Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer. BMC cancer, 20 (1)10.1186/s12885-020-06885-3
    Other University of Auckland co-authors: Dean Singleton
  • Ameratunga, R., Lehnert, K., Leung, E., Comoletti, D., Snell, R., Woon, S.-T., ... McKee, J. (2020). Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection. The New Zealand medical journal, 133 (1515), 112-118.
    Other University of Auckland co-authors: Klaus Lehnert, Shanthi Ameratunga, Helen Petousis-Harris, Russell Snell
  • Hanif, M., Arshad, J., Astin, J. W., Rana, Z., Zafar, A., Movassaghi, S., ... Reynisson, J. (2020). A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor. Angewandte Chemie (International ed. in English)10.1002/anie.202005758
    Other University of Auckland co-authors: Tilo Söhnel, Christian Hartinger, Muhammad Hanif, Stephen Jamieson
  • Ferraro-Peyret, C., Askarian-Amiri, M. E., Sarkar, D., Joseph, W. R., Hansji, H., Baguley, B. C., & Leung, E. Y. (2020). SOX2OT Long Noncoding RNA Is Regulated by the UPR in Oestrogen Receptor-Positive Breast Cancer. Sci, 2 (24)10.3390/sci2020024
  • Pilkington, L. I., Sparrow, K., Rees, S. W. P., Paulin, E. K., van Rensburg, M., Xu, C. S., ... Leung, E. (2020). Development, synthesis and biological investigation of a novel class of potent PC-PLC inhibitors. European journal of medicinal chemistry, 19110.1016/j.ejmech.2020.112162
    Other University of Auckland co-authors: Ivanhoe Leung, Lisa Pilkington, Shaun Rees, Emily Paulin, Ries Langley, David Barker

Identifiers

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 0, Room 002
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand

Web links